Literature DB >> 19464069

Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status.

Joan Tordjman1, Christine Poitou, Danielle Hugol, Jean-Luc Bouillot, Arnaud Basdevant, Pierre Bedossa, Michèle Guerre-Millo, Karine Clement.   

Abstract

BACKGROUND/AIMS: Recently we showed that macrophage accumulation in omental adipose tissue is associated with liver fibro-inflammation in morbidly obese subjects. Here, we evaluated the influence of glycemic status and extended the analysis to the spectrum of obesity-linked liver damage.
METHODS: Liver biopsies, subcutaneous and omental adipose tissue were collected in 132 obese subjects during gastric bypass surgery. HAM56+ adipose tissue macrophages were counted in subjects classified by liver histopathology and by their degree of insulin resistance.
RESULTS: In the whole population, the number of omental macrophages increased with the score of steatosis, the non-alcoholic fatty liver disease activity score, the stage of fibrosis and with fibro-inflammation index. None of these relationships were significant with subcutaneous macrophage count. In insulin-sensitive participants, omental macrophages accumulation was higher in subjects with high indexes of fibro-inflammation (p=0.012 vs. low indexes). In insulin-resistant including type 2 diabetic participants, omental macrophage count was higher both in subjects with high scores of steatosis and in subjects with high indexes of fibro-inflammation (p<0.05 vs. low scores).
CONCLUSIONS: Macrophage accumulation in omental adipose tissue is associated with aggravated steatosis and fibro-inflammation in insulin-resistant obese subjects independently of altered glycemic status.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464069     DOI: 10.1016/j.jhep.2009.02.031

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  30 in total

Review 1.  Concise Review: Macrophages: Versatile Gatekeepers During Pancreatic β-Cell Development, Injury, and Regeneration.

Authors:  Naomi Van Gassen; Willem Staels; Eva Van Overmeire; Sofie De Groef; Mozhdeh Sojoodi; Yves Heremans; Gunter Leuckx; Mark Van de Casteele; Jo A Van Ginderachter; Harry Heimberg; Nico De Leu
Journal:  Stem Cells Transl Med       Date:  2015-04-06       Impact factor: 6.940

Review 2.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

3.  Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

Authors:  Jonathan Barr; Mercedes Vázquez-Chantada; Cristina Alonso; Miriam Pérez-Cormenzana; Rebeca Mayo; Asier Galán; Juan Caballería; Antonio Martín-Duce; Albert Tran; Conrad Wagner; Zigmund Luka; Shelly C Lu; Azucena Castro; Yannick Le Marchand-Brustel; M Luz Martínez-Chantar; Nicolas Veyrie; Karine Clément; Joan Tordjman; Philippe Gual; José M Mato
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

4.  Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.

Authors:  Emma Börgeson; Andrew M F Johnson; Yun Sok Lee; Andreas Till; Gulam Hussain Syed; Syed Tasadaque Ali-Shah; Patrick J Guiry; Jesmond Dalli; Romain A Colas; Charles N Serhan; Kumar Sharma; Catherine Godson
Journal:  Cell Metab       Date:  2015-06-04       Impact factor: 27.287

5.  Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD.

Authors:  Ryan D Sheldon; Kayla M Kanosky; Kevin D Wells; Lili Miles; James W Perfield; Stavra Xanthakos; Thomas H Inge; R Scott Rector
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

6.  The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity.

Authors:  Jean O'Connell; Lydia Lynch; Tom J Cawood; Anna Kwasnik; Niamh Nolan; Justin Geoghegan; Aiden McCormick; Cliona O'Farrelly; Donal O'Shea
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

7.  Overweight and Obesity before, during and after Pregnancy: Part 1: Pathophysiology, Molecular Biology and Epigenetic Consequences.

Authors:  J H Stupin; B Arabin
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-07       Impact factor: 2.915

8.  Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.

Authors:  Geraldine J Ooi; Paul R Burton; Jacqueline Bayliss; Arthe Raajendiran; Arul Earnest; Cheryl Laurie; William W Kemp; Catriona A McLean; Stuart K Roberts; Matthew J Watt; Wendy A Brown
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

9.  Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease.

Authors:  Lindsay T Fourman; Takara L Stanley; Isabel Zheng; Chelsea S Pan; Meghan N Feldpausch; Julia Purdy; Julia Aepfelbacher; Colleen Buckless; Andrew Tsao; Kathleen E Corey; Raymond T Chung; Martin Torriani; David E Kleiner; Colleen M Hadigan; Steven K Grinspoon
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

Review 10.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.